VRAX(VRAX)
VRAX
Q4 2026 EPS Estimate
$-1.75
Dec 2, 2026
Revenue Estimate
$12,423
Analyst Sentiment
Wall St. Consensus
Buy1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$1.00
-64.5%
Consensus
$1.00
-64.5%
Bull
$1.00
-64.5%
12-Month Target Range1 analyst
$1.00$1.00$1.00
Current $2.82Consensus
Current Price
$2.82
Above Consensus
$1.82
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-90.00%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E |
|---|---|
| Revenue Avg | $4,000 |
| Low | $4,000 |
| High | $4,000 |
| EBITDA Avg | $-2M |
| Low | $-2M |
| High | $-2M |
| EBIT Avg | $-2M |
| Low | $-2M |
| High | $-2M |
| Net Income Avg | $-2M |
| Low | $-2M |
| High | $-2M |
| EPS Avg | $-6.00 |
| Low | $-6.00 |
| High | $-6.00 |
| Analysts (Rev / EPS) | 1 / 1 |
Quarterly
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $13,893 |
| Low | $13,893 |
| High | $13,893 |
| EBITDA Avg | $-310,276 |
| Low | $-310,276 |
| High | $-310,276 |
| EBIT Avg | $-654,000 |
| Low | $-654,000 |
| High | $-654,000 |
| Net Income Avg | $-695,784 |
| Low | $-695,784 |
| High | $-695,784 |
| EPS Avg | $-1.75 |
| Low | $-1.75 |
| High | $-1.75 |
| Analysts (Rev / EPS) | 1 / 1 |